Physician profile
Julia A Miller
NPI 1619962883
$14,442.91
in general payments reported to CMS, 2019-2025
46 companies · $1,373 in 2025
The $1,373 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,135 · 2020: $1,795 · 2021: $1,948 · 2022: $2,165 · 2023: $2,288 · 2024: $2,738 · 2025: $1,373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,240 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,240.15 |
| Education | $159.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,689.33 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $2,324.63 | 2019-2025 | Tezspire, Airsupra, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,375.91 | 2019-2025 | Spiriva Respimat, Stiolto Respimat, Ofev |
| Grifols USA, LLC | $791.28 | 2019-2025 | Prolastin-C Liquid |
| Electromed, INC. | $667.71 | 2019-2025 | Smartvest |
| Amgen INC. | $594.06 | 2021-2025 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $588.37 | 2019-2025 | Dupixent |
| Janssen Pharmaceuticals, INC | $574.41 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $550.18 | 2022-2024 | Acthar |
| Genzyme Corporation | $518.03 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $439.96 | 2019-2024 | Uptravi, Opsumit |
| Philips North America LLC | $425.72 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Pfizer INC. | $290.63 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $265.52 | 2019-2023 | |
| Abbvie INC. | $207.42 | 2021-2025 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $170.47 | 2019-2023 | Yupelri |
| Teva Pharmaceuticals USA, INC. | $169.41 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $161.31 | 2019-2024 | Keytruda |
| Baxter Healthcare | $158.64 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Insmed, INC. | $157.22 | 2021-2025 | Arikayce |
| Genentech USA, INC. | $152.70 | 2019-2022 | |
| Fujifilm Healthcare Americas Corporation | $144.69 | 2024 | Fujifilm |
| Shionogi INC | $126.65 | 2023-2024 | Fetroja |
| Verona Pharma, INC. | $121.39 | 2025 | Ohtuvayre |
| Pulmonx Corporation | $108.03 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $85.03 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $68.53 | 2020-2023 | Glassia |
| Shire North American Group INC | $62.42 | 2019 | |
| Portola Pharmaceuticals, LLC | $54.28 | 2019 | |
| Inari Medical, INC. | $44.75 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Circassia INC. | $34.10 | 2019 | |
| Olympus America INC. | $27.84 | 2019 | |
| Alexion Pharmaceuticals, INC. | $27.25 | 2019-2022 | |
| Ani Pharmaceuticals, INC. | $27.03 | 2025 | Purified Cortrophin Gel |
| Liquidia Technologies, INC. | $26.85 | 2025 | Yutrepia |
| Medtronic, INC. | $26.80 | 2021 | |
| La Jolla Pharmaceutical Company | $26.24 | 2019 | |
| Mallinckrodt Enterprises LLC | $21.60 | 2019 | |
| Allergan, INC. | $21.39 | 2020 | |
| United Therapeutics Corporation | $20.07 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.32 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $19.06 | 2024 | Eliquis |
| Astellas Pharma US INC | $18.88 | 2020 | |
| Sanofi-Aventis U.S. LLC | $13.76 | 2020 | |
| Nuwellis, INC. | $12.04 | 2023 | Aquadex Smartflow Console |
| Vapotherm INC | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.